Status:
UNKNOWN
Return to Work - Will Brief Intervention Reduce Opioid-induced Back Pain?
Lead Sponsor:
University Hospital, Akershus
Collaborating Sponsors:
Et liv i bevegelse (ELIB)
Conditions:
Opioid Dependence
Low Back Pain
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
Background Back pain is among the most common cause for sick leave in the working population and is the main cause of years lived with disability globally. In Norway, about 30% report to live with chr...
Eligibility Criteria
Inclusion
- age 18-67 years, admitted from their GP to Ahus due to back pain,
- daily use of opioids such as ≥ 30 mg codeine or ≥ 45 mg tramadol or ≥ 3 mg oxycodone or other opioids corresponding to a morphine equivalent dose ≥ 10-20 mg
Exclusion
- cauda equina syndrome
- recent surgery (within 1 month)
- pregnancy
- psychiatric disease
- rheumatic disease
- diabetic polyneuropathy
- cancer
- insufficient proficiency in the Norwegian language
- no remaining work potential and/or permanent sick pension.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05437861
Start Date
August 1 2022
End Date
January 1 2023
Last Update
June 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.